Kimberly A. Guedes

Kimberly A. Guedes is a seasoned executive with extensive experience in clinical operations and drug development across various companies. Currently serving as Vice President of Clinical Operations at Intensity Therapeutics, Inc., Kimberly leads global clinical teams in oncology and neurology trials, developing oversight frameworks for Phase III studies. Previous roles include Vice President of Clinical Operations at GLIAL Consulting and KeifeRx, as well as Executive Director at Centrexion Therapeutics Corp., where leadership was provided in clinical development and operational strategy. Additionally, Kimberly has held significant positions at BARC Global Central Laboratory, QED Pharmaceuticals, Clinsys Clinical Research, INC Research, and Janssen Pharmaceutica. Educational qualifications include multiple MBA degrees from the University of Dayton and a Bachelor of Science in Nursing from Salve Regina University.